Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid, and Tau in Older Adults (IPAT Study)

NCT05331144 is registered in ClinicalTrials.gov with Rong Zhang as lead sponsor.

NCT NCT05331144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05331144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid, and Tau in Older Adults (IPAT Study)
Lead sponsor
Rong Zhang
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 25, 2022
Completion date
August 31, 2028
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitively normal older adults, family history of dementia, hypertension, subjective cognitive decline